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July 2009224 Forbesevaluation has alreadymet several times, and data have been
collected with a strict control of the concordance with
patient’s records. Interim analysis is due September 2009,
with the initial publication by the end of 2009.
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Several multicenter randomized trials have compared endo-
vascular and open repair options in good-risk aneurysm pa-
tients, including the Comparison of Endovascular Aneurysm
Repair with Open Repair in Patients with Abdominal Aortic
Aneurysm (EVAR-1) and Dutch Randomised Endovascular
Aneurysm Management (DREAM) European studies that re-
ported an early survival advantage after endovascular repair. The
Veterans Affairs Study in the United States (OVER) completed
recruitment of 881 patients in April 2007 and results are
expected soon.
The Anévrisme de l’aorte abdominale: Chirurgie versus Endo-
prothèse (ACE) study from France uses a similar study protocolscribes the challenges the French investigators have faced with
regulatory bodies and funding agencies resulting in patient recruit-
ment lagging 5 years after initial ethics approval. This environment
may have contributed to the emergence of laparoscopic aortic
surgery as a minimally invasive therapeutic option, which French
surgeons have been pivotal in developing.
The ACE investigators should be commended for their perse-
verance in completing this study. One wonders, though, with 306
patients recruited whether we will see a repeat of the early DREAM
results (345 patients), where the early survival advantage was
similar to that achieved with EVAR-1 and was viewed as clinically
significant, but failed to reach statistical significance. Regardless,
we await the results, which should be interesting and valuable.
